ARTICLE | Clinical News
EGEN-001: Phase I started
July 30, 2007 7:00 AM UTC
The company began an open-label, dose-escalation, U.S. Phase I trial in up to 30 patients with recurrent epithelial ovarian cancer to evaluate EGEN-001 plus chemotherapy. ...